D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$410M |
| 2 |
Chevron
CVX
|
+$400M |
| 3 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$381M |
| 4 |
Williams Companies
WMB
|
+$300M |
| 5 |
SLB Ltd
SLB
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$358M |
| 3 |
Biogen
BIIB
|
+$306M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$298M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 11.41% |
| 2 | Technology | 9.4% |
| 3 | Healthcare | 8.95% |
| 4 | Consumer Discretionary | 8.78% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
News Corp Class A
NWSA
$14.5B
| $38.4M | 0.06% |
2,629,503
-318,534
| -11% | -$4.89M |
|
402
Visteon
VC
$2.77B
| $38.4M | 0.06% |
365,374
-169,934
| -32% | -$17.9M |
|
403
PUT
Illumina
ILMN
$29.4B
| $38.3M | 0.06% |
180,106
+10,794
| +6% | +$2.11M |
|
|
CSC
404
DELISTED
Computer Sciences
CSC
| $38.1M | 0.06% |
1,378,193
+263,336
| +24% | +$7.38M |
|
|
GPOR
405
DELISTED
Gulfport Energy Corp.
GPOR
| $38M | 0.06% |
944,144
+394,354
| +72% | +$18.1M |
|
406
Bristol-Myers Squibb
BMY
$127B
| $37.7M | 0.06% |
567,185
+473,235
| +504% | +$31.2M |
|
407
LKQ Corp
LKQ
$6.58B
| $37.6M | 0.06% |
1,242,161
+196,970
| +19% | +$5.47M |
|
408
Timken Company
TKR
$9.82B
| $37.6M | 0.06% |
1,027,323
+479,056
| +87% | +$19.1M |
|
409
CALL
American International
AIG
$41.9B
| $37.3M | 0.06% |
603,800
+246,800
| +69% | +$14.6M |
|
|
CTRA
410
DELISTED
Coterra Energy
CTRA
| $37.3M | 0.06% |
1,182,533
+268,741
| +29% | +$8.97M |
|
|
LGF
411
DELISTED
Lions Gate Entertainment
LGF
| $37.2M | 0.06% |
+1,004,200
| New | +$33.5M |
|
412
PUT
CVS Health
CVS
$137B
| $37.1M | 0.06% |
353,500
-274,900
| -44% | -$28.1M |
|
413
Global Payments
GPN
$22.1B
| $37M | 0.06% |
715,852
+513,252
| +253% | +$26.3M |
|
|
CXP
414
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $36.4M | 0.05% |
1,482,261
+770,757
| +108% | +$20.3M |
|
415
PUT
AbbVie
ABBV
$458B
| $36.3M | 0.05% |
539,960
+389,960
| +260% | +$25.5M |
|
416
Masco
MAS
$16B
| $36.2M | 0.05% |
1,545,600
-266,919
| -15% | -$6.32M |
|
417
Fluor
FLR
$7.29B
| $36.1M | 0.05% |
681,315
+477,008
| +233% | +$27.6M |
|
418
Trimble
TRMB
$12.3B
| $36.1M | 0.05% |
1,539,012
+944,865
| +159% | +$23.1M |
|
419
PUT
BP
BP
$113B
| $36M | 0.05% |
1,072,024
-169,108
| -14% | -$5.92M |
|
|
KING
420
DELISTED
KING DIGITAL ENTMT PLC ORD SHS (IRL)
KING
| $36M | 0.05% |
2,524,906
+719,618
| +40% | +$11.2M |
|
|
IHS
421
DELISTED
IHS INC CL-A COM STK
IHS
| $35.8M | 0.05% |
278,690
-359,750
| -56% | -$44.9M |
|
|
SIOX
422
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $35.7M | 0.05% |
+218,750
| New | +$37.1M |
|
423
Alibaba
BABA
$269B
| $35.6M | 0.05% |
433,329
-138,005
| -24% | -$11.9M |
|
|
FLIR
424
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $35.4M | 0.05% |
1,147,126
-426,663
| -27% | -$13.3M |
|
|
RPTP
425
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
| $35.2M | 0.05% |
2,229,161
+1,339,131
| +150% | +$16.3M |
|
Similar funds
D.E. Shaw & Co's Q2 2015 Portfolio in Review
As of Q2 2015, D.E. Shaw & Co held 4,083 positions worth $67.1B, up 2.8% from $65.3B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co's Q2 2015 filing shows 504 new, 1,541 increased, 1,228 reduced and 364 closed positions. Its largest new stake was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $479M.
By sector, the portfolio is most concentrated in Energy at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Healthcare.
- D.E. Shaw & Co's largest Q2 2015 buy was State Street Energy Select Sector SPDR ETF: 3,541,400 shares worth $133M.
- D.E. Shaw & Co added most to Gilead Sciences in Q2 2015, an estimated $410M increase.
- D.E. Shaw & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $479M.
- D.E. Shaw & Co fully exited TRW AUTOMOTIVE HOLDINGS CORP in Q2 2015, selling an estimated $164M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $67.1B portfolio in Q2 2015.
- D.E. Shaw & Co opened 504 new positions and closed 364 in Q2 2015.
- D.E. Shaw & Co's portfolio value rose 2.8% quarter-over-quarter to $67.1B.
Based on D.E. Shaw & Co's 13F filing for Q2 2015, filed 14 Aug 2015.